🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Part A: The primary objective is to evaluate the safety and tolerability of...
Status
Completed
Location
Biokinetic Europ Ltd
Start Date
2015-05
Trial ID
NCT02459262
Treatments Being Tested
The goal of this follow-up study is to investigate the persistence of the i...
Status
Terminated
Location
Simbec-Orion Clinical Pharmacology
Start Date
2024-01-18
Trial ID
NCT06280157
Treatments Being Tested
The main objective of the study is to evaluate the persistence of the immun...
Status
Active Not Recruiting
Location
Hvidovre Hospital - Department Of Obstetrics And Gynaecology
Start Date
2025-03-07
Trial ID
NCT06592586
Treatments Being Tested
This is a phase II, multicentre, multinational, randomized, parallel group,...
Status
Completed
Location
Aarhus University Hospital; Skejby
Start Date
2022-02-17
Trial ID
NCT05154578
Treatments Being Tested
The study is a randomised, double-blind, placebo-controlled, parallel group...
Status
Completed
Location
University Hospital Ghent - Centrum voor Vaccinologie (CEVAC) department
Start Date
2023-03-01
Trial ID
NCT05782179
Treatments Being Tested
A randomised, placebo-controlled, double-blind study to evaluate the safety...
Status
Completed
Location
Empilweni Services and Research Unit (ESRU), Rahima Moosa Mother and Child Hospital
Start Date
2020-11-19
Trial ID
NCT04596878
Treatments Being Tested
The main objectives of the study are to demonstrate the non-inferiority of ...
Status
Unknown
Location
Multiple Locations
Start Date
2024-12-17
Trial ID
NCT06494475
Treatments Being Tested
This is an open label booster vaccine follow-up study. Participants who had...
Status
Completed
Location
Simbec Clinical Pharmacology
Start Date
2021-08-17
Trial ID
NCT05005247
Treatments Being Tested
A Phase I, randomised, single centre, double-blind, placebo-controlled, par...
Status
Completed
Location
Simbec Research Limited
Start Date
2019-01-09
Trial ID
NCT03807245